The activation of the NF-κB signaling pathway contributes to the development of depression [35]; the main mechanism behind this process is that NF-κB can promote the release of inflammatory factors, such as IL-1β, IL-6, and TNF-α, and trigger neuroinflammation, finally leading to depression [36]. Here, NFKB1 is linked to depressive symptom measurement.